CD82/Kai-1 Antibody (B-L2) Summary
Human CD82 transfected murine mastocytoma cell line P815
Integral membrane protein
recognises the human CD82 antigen, a 50-53kD cell surface protein.
IgG1
Monoclonal
Mouse
CD82
Protein A or G purified
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
Applications/Dilutions
- Flow Cytometry 1:10-1:1000
Flow Cytometry Use 10ul of the neat antibody to label 10<sup>6</sup> cells. Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
Reactivity Notes
Not yet tested in other species.
Packaging, Storage & Formulations
Store at 4C. Do not freeze.
PBS (pH 7.4) and 1.0% BSA
0.1% Sodium Azide
Protein A or G purified
Alternate Names for CD82/Kai-1 Antibody (B-L2)
- CD82 antigenC33
- CD82 molecule
- CD82
- IA4
- IA4C33 antigen
- Inducible membrane protein R2
- KAI1
- KAI1GR15
- kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyteantigen, antigen detected by monoclonal and IA4))
- Metastasis suppressor Kangai-1
- R2
- SAR2
- SAR2tetraspanin-27
- ST6
- ST6tspan-27
- Suppressor of tumorigenicity 6 protein
- Tetraspanin-27
- TSPAN27
- Tspan-27
- TSPAN274F9
Background
CD82, a member of the tetraspanin (TM4SF) family, is a suppressor of tumorigenicity 6 and of metastasis in prostate, pancreatic, hepatocellular, cervical and colorectal carcinomas. It is expressed by T cells, NK cells, monocytes, granulocytes and platelets. CD82 associates with CD4 or CD8 and delivers co-stimulatory signals for the TCR/CD3 pathway
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
product targets :　Integrin inhibitors